Specialized Monitors are Gaining Popularity in the Remote Patient Monitoring Market

Increasing burden of chronic diseases and rising awareness about necessity of early warning signs are fuelling the demand of remote patient monitors

The global remote patient monitoring market was valued at USD 975.0 million in 2020, and it is expected to reach USD 3,244.9 million by 2027, with a CAGR of 18.9%, during the forecast period.

Remote patient monitoring technology can monitor patient health outside a healthcare setting. This monitoring can be done at home or at any place where healthcare delivery is not accessible. Rising geriatric population, Covid-19 cases, entry of innovative products, and investment by market players are some of the major drivers of the global remote patient monitor’s market.

Various physiological parameters are monitors including blood pressure, blood oxygen level, blood glucose level, heart rate, body temperature, fetal heart rate, sleep monitoring, brain monitoring, and many others. Remote Patient Monitoring (RPM) enables early detection of deterioration and thereby reduces emergency department visits, hospitalizations, the duration of hospital stays, and healthcare expenditure. RPM majorly use for patient suffering from chronic obstructive pulmonary disease, diabetes, hypertension, dementia, congestive heart failure, COVID-19, and infertility. Additionally, RPM is also useful to monitor geriatric people continuously as they are at risk for falls. The sensor monitors an individual’s location, angular velocity, and apply a mathematical algorithm to predict the chances for falls, and alert caregivers if the individual has fallen. Increasing geriatric population across the globe is expected to accelerate the demand for remote patient monitoring during the forecast period.

With the COVID-19 pandemic, health systems or hospitals rapidly adopted remote patient monitoring technology to maintain social distancing and thereby control viral spread. Patients suffering from COVID – 19 need to monitor blood oxygen level and heart rate regularly. Hence, it is expected to increase the demand of RPM technology during the forecast period.

Large number of diabetes patients is responsible for dominance of segment in the market. Large patient pool and increasing adoption by patients are expected to accelerate the market growth. With the increasing demand of technology, large number of healthcare providers are investing in remote patient monitoring solutions for high-risk chronically ill patients. For instance, in March 2021, Dozee launched a remote patient monitoring solution which is a contactless, Dozee Pro, for hospital settings. More than 70 hospitals partnered with Dozee in fewer than 3 months to enable RPM at their facility.  

Key players operating in the market are American Telecare; Biotronik; Bosch; Honeywell; Roche; Philips Healthcare; Intel; Health anywhere Inc.; Johnson & Johnson; Welch Allyn; and Covidien Plc.    

Key Findings:

• Based on the product type, specialized monitor segment accounted for the largest share of the market in 2020 due to it’s ability to monitor pre and post-surgery symptoms and prevent complications.
• Based on application, diabetes accounted for the largest share of the remote patient monitoring market in 2020 and is expected to maintain significant share during the forecast period. The cardiovascular diseases segment is expected to propel the market at the highest rate in coming years.
• Based on end-use, the hospital segment held the largest share in the market and is expected to maintain it’s dominance during the forecast period. This can be attributed to presence of large patient pool in hospitals. However, home healthcare is expected to observe strong growth during the forecast period due to cost-efficiency and patient convenience. 
• Geographically, North America held the largest share of the remote patient monitoring market. However, the Asia Pacific region is expected to observe the fastest growth during the forecast period.

Recent News:

• In August 2020, Stasis Labs launched a mobile-connected remote patient monitoring platform in the U.S. to use in hospital and outpatient care. The Stasis system of the company tracks six major vital signs in the people.
• In July 2020, Philips collaborated with BioIntelliSense to enhance patient monitoring remotely for at-risk patients from the hospital to the home. Philips integrated BioSticker sensor, the BioIntelliSense sensor, to expand its remote patient monitoring solutions for patients outside the hospital.
• In July 2020, Phillips launched Tempus ALS, pre-hospital wireless monitoring solution in the U.S. It consists of remote professional defibrillator (Tempus LS-Manual) and Tempus Pro, a portable vital signs monitor for remote application.